166 related articles for article (PubMed ID: 38069119)
41. Activation of brain serotonergic system by repeated intracerebral administration of 5-hydroxytryptophan (5-HTP) decreases the expression and activity of liver cytochrome P450.
Rysz M; Bromek E; Daniel WA
Biochem Pharmacol; 2016 Jan; 99():113-22. PubMed ID: 26581122
[TBL] [Abstract][Full Text] [Related]
42. Intestinal and hepatic expression of cytochrome P450s and mdr1a in rats with indomethacin-induced small intestinal ulcers.
Kawauchi S; Nakamura T; Yasui H; Nishikawa C; Miki I; Inoue J; Horibe S; Hamaguchi T; Tanahashi T; Mizuno S
Int J Med Sci; 2014; 11(12):1208-17. PubMed ID: 25317066
[TBL] [Abstract][Full Text] [Related]
43. [Modulation of the activities and mRNA expression of cytochrome P450 isoenzymes in rat liver by Panax gingseng and coadministration with Veratrum nigrum].
Wang YG; Gao Y; Chai BX; Chen P; Tan HL; Zhao YH; Xiao CR; Sun YY; Zhu LJ
Zhongguo Zhong Yao Za Zhi; 2004 Apr; 29(4):366-70. PubMed ID: 15706880
[TBL] [Abstract][Full Text] [Related]
44. CYP2C11 and CYP2B1 are major cytochrome P450 forms involved in styrene oxidation in liver and lung microsomes from untreated rats, respectively.
Nakajima T; Wang RS; Elovaara E; Gonzalez FJ; Gelboin HV; Vainio H; Aoyama T
Biochem Pharmacol; 1994 Aug; 48(4):637-42. PubMed ID: 8080435
[TBL] [Abstract][Full Text] [Related]
45. Molecular Mechanisms of the Regulation of Liver Cytochrome P450 by Brain NMDA Receptors and via the Neuroendocrine Pathway-A Significance for New Psychotropic Therapies.
Pukło R; Bromek E; Haduch A; Basińska-Ziobroń A; Kuban W; Daniel WA
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069162
[TBL] [Abstract][Full Text] [Related]
46. Induction of cytochrome P450 enzymes in rat liver by two conazoles, myclobutanil and triadimefon.
Sun G; Grindstaff RD; Thai SF; Lambert GR; Tully DB; Dix DJ; Nesnow S
Xenobiotica; 2007 Feb; 37(2):180-93. PubMed ID: 17484520
[TBL] [Abstract][Full Text] [Related]
47. Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat.
Kobayashi K; Urashima K; Shimada N; Chiba K
Drug Metab Dispos; 2003 Jul; 31(7):833-6. PubMed ID: 12814958
[TBL] [Abstract][Full Text] [Related]
48. Age-related changes in hepatic expression and activity of cytochrome P450 in male rats.
Yun KU; Oh SJ; Oh JM; Kang KW; Myung CS; Song GY; Kim BH; Kim SK
Arch Toxicol; 2010 Dec; 84(12):939-46. PubMed ID: 20130842
[TBL] [Abstract][Full Text] [Related]
49. Expression of hepatic and ovarian cytochrome P450 during estrous cycle in rats.
Lee SY; Oh SJ; Yun KU; Kim HM; Kim BH; Lee K; Kim SK
Arch Toxicol; 2012 Jan; 86(1):75-85. PubMed ID: 21717108
[TBL] [Abstract][Full Text] [Related]
50. Comparative induction of CYP3A and CYP2B in rat liver by 3-benzoylpyridine and metyrapone.
Murray M; Sefton RM; Martini R; Butler AM
Chem Biol Interact; 1998 Jun; 113(3):161-73. PubMed ID: 9717516
[TBL] [Abstract][Full Text] [Related]
51. Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies.
Schmider J; Greenblatt DJ; von Moltke LL; Harmatz JS; Duan SX; Karsov D; Shader RI
Pharmacology; 1996 Feb; 52(2):125-34. PubMed ID: 8851634
[TBL] [Abstract][Full Text] [Related]
52. The influence of soybean extract on the expression level of selected drug transporters, transcription factors and cytochrome P450 genes encoding phase I drug-metabolizing enzymes.
Bogacz A; Bartkowiak-Wieczorek J; Mikołajczak PŁ; Rakowska-Mrozikiewicz B; Grześkowiak E; Wolski H; Czerny B; Mrozikiewicz PM
Ginekol Pol; 2014 May; 85(5):348-53. PubMed ID: 25011215
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature.
Greenberg WM; Citrome L
Clin Pharmacokinet; 2017 May; 56(5):493-503. PubMed ID: 27722855
[TBL] [Abstract][Full Text] [Related]
54. Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice.
Roe AL; Howard G; Blouin R; Snawder JE
Int J Obes Relat Metab Disord; 1999 Jan; 23(1):48-53. PubMed ID: 10094576
[TBL] [Abstract][Full Text] [Related]
55. Differential effects of neuroleptic agents on hepatic cytochrome P-450 isozymes in the male rat.
Rane A; Liu Z; Levol R; Bjelfman C; Thyr C; Ericson H; Hansson T; Henderson C; Wolf CR
Biochim Biophys Acta; 1996 Aug; 1291(1):60-6. PubMed ID: 8781526
[TBL] [Abstract][Full Text] [Related]
56. Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes.
Lou D; Bao SS; Li YH; Lin QM; Yang SF; He JY
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):611-618. PubMed ID: 30825074
[TBL] [Abstract][Full Text] [Related]
57. Analysis of cytochrome P450 and phase II conjugating enzyme expression in adult male rat hepatocytes.
Davila JC; Morris DL
In Vitro Cell Dev Biol Anim; 1999 Mar; 35(3):120-30. PubMed ID: 10476907
[TBL] [Abstract][Full Text] [Related]
58. Monoclonal antibody-directed assessment of toluene induction of rat hepatic cytochrome P450 isozymes.
Wang RS; Nakajima T; Park SS; Gelboin HV; Murayama N
Biochem Pharmacol; 1993 Aug; 46(3):413-9. PubMed ID: 8347164
[TBL] [Abstract][Full Text] [Related]
59. Expression and distribution of cytochrome P450 enzymes in male rat kidney: effects of ethanol, acetone and dietary conditions.
Ronis MJ; Huang J; Longo V; Tindberg N; Ingelman-Sundberg M; Badger TM
Biochem Pharmacol; 1998 Jan; 55(2):123-9. PubMed ID: 9448734
[TBL] [Abstract][Full Text] [Related]
60. Hormonal perturbation as a possible mechanism for the alteration of cytochrome P450 by cyclophosphamide.
McClure MT; Stupans I
Biochem Pharmacol; 1995 Jun; 49(12):1827-36. PubMed ID: 7598745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
